Neuropathic pain in children with cancer

Journal of Pediatric Oncology Nursing

Volumn 21, Issue 6, 2004, Pages 350-357

  Jacob, Eufemia ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer pain; Neuropathic pain; Pain assessment; Pain management

Indexed keywords

AMANTADINE; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CLONAZEPAM; DESIPRAMINE; DEXTROMETHORPHAN; GABAPENTIN; IMIPRAMINE; KETAMINE; MEMANTINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PHENYTOIN; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

BALANCE DISORDER; CANCER MORTALITY; CANCER PAIN; CHILDHOOD CANCER; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; DISSOCIATIVE DISORDER; DIZZINESS; DRUG EFFICACY; HEADACHE; HUMAN; MEDICAL RESEARCH; MOOD DISORDER; MOTOR DYSFUNCTION; MUTISM; NAUSEA; NERVE BLOCK; NERVOUS TISSUE; NEUROPATHIC PAIN; NURSE; ORTHOSTATIC HYPOTENSION; PAIN ASSESSMENT; QUALITY OF LIFE; REVIEW; SEDATION; SEIZURE; SLEEP DISORDER; SOMNOLENCE; VISUAL DISORDER; WEIGHT GAIN; XEROSTOMIA;

ANALGESICS; ANALGESICS, OPIOID; CHILD; HUMANS; NEOPLASMS; NEURALGIA; PAIN MEASUREMENT; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 8444240858     PISSN: 10434542     EISSN: None     Source Type: Journal    
DOI: 10.1177/1043454204270251     Document Type: Review

References (47)

1. Agency of Health Care Policy and Research. (1994). Management of cancer pain: Clinical practice guideline No. 9. Rockville, MD: Agency of Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service.
2. Allen, R. (1998). Neuropathic pain: Mechanisms and clinical assessment. In R. Payne, R. Patt, & C. Hill (Eds.), Assessment and treatment of cancer pain (Vol. 12, pp. 159-173). Seattle, WA: IASP Press.
3. Arner, S., & Meyerson, B. (1988). Level of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain, 33, 11-23.
4. Baker, W., Royer, G., & Weiss, R. (1991). Cytarabine and neurologic toxicity. Journal of Clinical Oncology, 9, 679-693.
5. Berde, C., Fischel, N., Filardi, J., Coe, C., Grier, H., & Bernstein, S. (1989). Caudal epidural morphine for an infant with advanced neuroblastoma. Pain, 36, 219-223.
6. Berde, C., Sethna, N., Conrad, L., Hershenson, M., & Shillito, J. (1990). Subarachnoid bupivacaine analgesia for seven months for a patient with a spinal cord tumor. Anesthesiology, 72, 1094-1096.
7. Berde, C., Sethna, N., Fisher, D., Kahn, C., Chandler, P., & Grier, H. (1990). Celiac plexus blockade for a 3 year old boy with hepatoblastoma and refractory pain. Pediatrics, 86, 779-781.
8. Boureau, F., Doubrere, J., & Luu, M. (1990). Study of verbal description in neuropathic pain. Pain, 42, 145-152.
9. Cherny, N. I., Thaler, H. T., Friedlander-Klar, H., Lapin, J., Foley, K. M., Houde, R., et al. (1994). Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: A combined analysis of controlled, single dose studies. Neurology, 44, 857-861.
10. Collins, J., Grier, H., Kinney, H., & Berde, C. (1995). Control of severe pain in children with terminal malignancy. Journal of Pediatrics, 126(4), 653-657.
11. Collins, J., Grier, H., Sethna, N., Wilder, R., & Berde, C. (1996). Regional anesthesia for pain associated with terminal pediatric malignancy. Pain, 65, 63-69.
12. Collins, J. J. (1996). Intractable pain in children with terminal cancer. Journal of Palliative Care, 12(3), 29-34.
13. Cooper, M., Keneally, J., & Kinchington, D. (1994). Continuous brachial plexus neural blockade in a child with intractable cancer pain. Journal of Pain and Symptom Management, 9(4), 277-281.
14. Dellemijn, P. (1999). Are opioids effective in relieving neuropathic pain? Pain, 80, 453-462.
15. Dellemijn, P., Verbiest, H., Vliet, J. V., Roos, P., & Vecht, C. (1994). Medical theory of malignant nerve pain. A randomized double-blind explanatory trial with naproxen versus slow-release morphine. European Journal of Cancer, 30, 1244-1250.
16. Dougherty, M., & DeBaun, M. R. (2003). Rapid increase of morphine and benzodiazepine usage in the last three days of life in children with cancer is related to neuropathic pain. Journal of Pediatrics, 142(4), 373-376.
17. Felsby, S., Nielsen, J., Arendt-Nielsen, L., & Jensen, T. (1996). NMDA receptor blockade in chronic neuropathic pain: A comparison of ketamine and magnesium chloride. Pain, 64, 283-291.
18. Fields, H. (1988). Can opiates relieve neuropathic pain? Pain, 35, 365.
19. Finley, G., & McGrath, P. (1998). Measurement of pain in infants and children. Seattle, WA: IASP Press.
20. Fischer, D., Knobf, M., & Durivage, H. (1993). The cancer chemotherapy handbook (4th ed.). St. Louis, MO: Mosby.
21. Grond, S., Zech, D., Difenback, C., Radbruch, L., & Lehmann, K. (1996). Assessment of cancer pain: A prospective evaluation in 2266 cancer patients referred to a pain service. Pain, 64, 107-114.
22. Haines, D., & Gaines, S. (1999). N of 1 randomized controlled trials of oral ketamine in patients with chronic pain. Pain, 83, 283-287.
23. Hilderley, L., Iwamoto, R., & Knobf, M. (2002). Pain and suffering in an adolescent with neuroblastoma. Cancer Practice, 10 (Suppl. 1), S4-S8.
24. Hockenberry-Eaton, M., Barrera, P., Brown, M., Bottomley, S., & O'Neill, J. (1999). Pain management in children with cancer. Houston: Texas Cancer Council.
25. Holland, J. F., Scharlau, C., Gailani, S., Krant, M. J., Olson, K. B., Horton, J., et al. (1973). Vincristine treatment of advanced cancer: A co-operative study of 392 cases. Cancer Research, 33, 1258-1264.
26. Jadad, A., Carroll, D., Glynn, C., Moore, R., & McQuay, M. (1992). Morphine responsiveness of chronic pain: Double blind randomized crossover study with patient controlled analgesia. Lancet, 339, 1367-1371.
27. Klepstad, P., Borchgrevnik, P., Hval, B., Flaat, S., & Kaasa, S. (2001). Long-term treatment with ketamine in a 12 year old girl with severe neuropathic pain caused by a cervical spinal tumor. Journal of Pediatric Hematology/Oncology, 23(9), 616-619.
28. Kupers, R., Konings, H., Adriaensen, H., & Cybels, J. (1991). Morphine differentially affects the sensory and effective pain ratings in neurogenic and idiopathic forms of pain. Pain, 47, 5-12.
29. Manfredi, P., Gonzales, G., Sady, R., Chandler, S., & Payne, R. (2003). Neuropathic pain in patients with cancer. Journal of Palliative Care, 19(2), 115-118.
30. Martin, L., & Hagen, N. (1997). Neuropathic pain in cancer patients: Mechanisms, syndromes, and clinical controversies. Journal of Pain and Symptom Management, 14, 99-117.
31. Marx, C. M., Stein, J., Tyler, M. K., Nieder, M. L., Shurin, S. B., & Blumer, J. L. (1997). Ketamine-midazolam versus meperidine-midazolam for painful procedures in pediatric oncology patients. Journal of Clinical Oncology, 15, 94-102.
32. Mathisen, L., Skjelbred, P., Skoglund, L., & Oye, I. (1995). Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain, 61, 214-220.
33. McCaffery, M., & Pasero, C. (1999). Pain clinical manual. St. Louis, MO: Mosby.
34. Miser, A., Dothage, J., Wesley, R., & Miser, J. (1987). The prevalence of pain in a pediatric and young adult cancer population. Pain, 29, 73-83.
35. Payne, R. (2000). Chronic pain: Challenges in the assessment and management of cancer pain. Journal of Pain and Symptom Management, 19, S12-S15.
36. Portenoy, R., Foley, K., & Inturrisi, C. (1990). The nature of opioid responsiveness and its implications for neuropathic pain: New hypotheses derived from studies of opioid infusions. Pain, 43, 273-286.
37. Portenoy, R., & Lesage, P. (1999). Management of cancer pain. Lancet, 353, 1695-1700.
38. Pud, D., Spitzer, A., Adler, R., Fried, G., & Yarnitsky, D. (1998). The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: A double blind, randomized, placebo controlled trial. Pain, 75, 349-354.
39. Sang, C. (2000). NMDA receptor antagonists in neuropathic pain: Experimental methods to clinical trials. Journal of Pain and Symptom Management, 79(Suppl. 1), S21-S25.
40. Siegal, T., & Haim, N. (1990). Cisplatin induced peripheral neuropathy: Frequent off-therapy deterioration, demyelinating syndromes, and muscle cramps. Cancer, 66, 1117-1123.
41. Sindrup, S., & Jensen, T. (1999). Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain, 83, 389-400.
42. Sindrup, S., & Jensen, T. (2001). Antidepressants in the treatment of neuropathic pain. In P. Handsson, H. L. Fields, & P. Marchettini (Eds.), Neuropathic pain: Pathophysiology and treatment (pp. 169-181). Seattle, WA: IASP Press.
43. Stute, P., Soukup, J., Matthias, M., Sabatowski, R., & Grond, S. (2003). Analysis and treatment of different types of neuropathic cancer pain. Journal of Pain and Symptom Management, 26(6), 1123-1128.
44. Takahashi, H., Miyazaki, M., Nanbu, T., Yanagida, H., & Morita, S. (1998). The NMDA-receptor antagonist ketamine abolishes neuropathic pain after epidural administration in a clinical case. Pain, 75(2-3), 391-394.
45. Thompson, S. W., Davis, L. E., Kornfeld, M., Hilgers, R. D., & Standefer, J. C. (1984). Cisplatin neuropathy: Clinical, electrophysiologic, morphologic, and toxicologic studies. Cancer Practice, 54, 1269-1275.
46. Weiden, P., & Wright, S. (1972). Vincristine neurotoxicity. New England Journal of Medicine, 286, 1369-1370.
47. World Health Organization. (1996). Cancer pain relief (2nd ed.). Geneva, Switzerland: Author.